Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Accounts Payables (2016 - 2026)

OptimizeRx's Accounts Payables history spans 16 years, with the latest figure at $1.6 million for Q4 2025.

  • On a quarterly basis, Accounts Payables fell 24.12% to $1.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.6 million, a 24.12% decrease, with the full-year FY2025 number at $1.6 million, down 24.12% from a year prior.
  • Accounts Payables hit $1.6 million in Q4 2025 for OptimizeRx, down from $2.0 million in the prior quarter.
  • Over the last five years, Accounts Payables for OPRX hit a ceiling of $3.4 million in Q1 2025 and a floor of $499279.0 in Q1 2021.
  • Historically, Accounts Payables has averaged $1.5 million across 5 years, with a median of $1.4 million in 2022.
  • Biggest five-year swings in Accounts Payables: crashed 36.9% in 2023 and later skyrocketed 298.46% in 2024.
  • Tracing OPRX's Accounts Payables over 5 years: stood at $606808.0 in 2021, then surged by 155.43% to $1.5 million in 2022, then surged by 43.68% to $2.2 million in 2023, then dropped by 3.19% to $2.2 million in 2024, then dropped by 24.12% to $1.6 million in 2025.
  • Business Quant data shows Accounts Payables for OPRX at $1.6 million in Q4 2025, $2.0 million in Q3 2025, and $2.0 million in Q2 2025.